James Edgemond - 15 Mar 2026 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
CFO AND TREASURER
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Issuer symbol
UTHR
Transactions as of
15 Mar 2026
Net transactions value
$0
Form type
4
Filing time
17 Mar 2026, 17:10:01 UTC
Previous filing
16 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
EDGEMOND JAMES CFO AND TREASURER C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING /s/ John S. Hess, Jr. under Power of Attorney 17 Mar 2026 0001636178

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise +10,380 +127% 18,564 15 Mar 2026 Direct F1, F2
transaction UTHR Common Stock Options Exercise +9,098 +49% 27,662 15 Mar 2026 Direct F1
transaction UTHR Common Stock Tax liability -4,682 -17% $536.12* 22,980 15 Mar 2026 Direct F3
transaction UTHR Common Stock Tax liability -4,104 -18% $536.12* 18,876 15 Mar 2026 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Restricted Stock Units Options Exercise -10,380 -100% $0.000000* 0 15 Mar 2026 Common Stock 10,380 Direct F1, F4
transaction UTHR Restricted Stock Units Options Exercise -9,098 -100% $0.000000* 0 15 Mar 2026 Common Stock 9,098 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
F2 Includes 42 shares of common stock acquired on March 4, 2026 under the United Therapeutics Employee Stock Purchase Plan.
F3 Represents the number of shares withheld by United Therapeutics for tax purposes, upon vesting of restricted stock units.
F4 Shares received upon vesting of performance-based restricted stock units on March 15, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. These restricted stock units were granted on March 15, 2023.